Detalhe da pesquisa
1.
Prognostic factors in Kaposi sarcoma, single centre experience.
Australas J Dermatol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760927
2.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996793
3.
The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.
J Med Virol
; 93(10): 5839-5845, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081337
4.
Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 184: 107347, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597304
5.
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy.
J Chemother
; 35(1): 29-38, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220928
6.
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Clin Genitourin Cancer
; 21(1): 175-182, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970759
7.
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
J Cancer Res Clin Oncol
; 148(12): 3537-3546, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616728